Improving Harmonization and Standardization of Expanded Newborn Screening Results by Optimization of the Legacy Flow Injection Analysis Tandem Mass Spectrometry Methods and Application of a Standardized Calibration Approach.

MS/MS inherited disorders interlaboratory performance laboratory methods and tools mass spectrometry newborns proficiency testing

Journal

Clinical chemistry
ISSN: 1530-8561
Titre abrégé: Clin Chem
Pays: England
ID NLM: 9421549

Informations de publication

Date de publication:
27 07 2022
Historique:
received: 11 12 2021
accepted: 28 03 2022
pubmed: 15 6 2022
medline: 30 7 2022
entrez: 14 6 2022
Statut: ppublish

Résumé

Newborn screening (NBS) laboratories in the United Kingdom adhere to common protocols based on single analyte cutoff values (COVs); therefore, interlaboratory harmonization is of paramount importance. Interlaboratory variation for screening analytes in UK NBS laboratories ranges from 17% to 59%. While using common stable isotope internal standards has been shown to significantly reduce interlaboratory variation, instrument set-up, sample extraction, and calibration approach are also key factors. Dried blood spot (DBS) extraction processes, instrument set-up, mobile-phase composition, sample introduction technique, and calibration approach of flow injection analysis-tandem mass spectrometry (FIA-MS/MS) methods were optimized. Inter- and intralaboratory variation of methionine, leucine, phenylalanine, tyrosine, isovaleryl-carnitine, glutaryl-carnitine, octanoyl-carnitine, and decanoyl-carnitine were determined pre- and postoptimization, using 3 different calibration approaches. Optimal recovery of analytes from DBS was achieved with a 35-min extraction time and 80% methanol (150 μL). Optimized methodology decreased the mean intralaboratory percentage relative SD (%RSD) for the 8 analytes from 20.7% (range 4.1-46.0) to 5.4% (range 3.0-8.5). The alternative calibration approach reduced the mean interlaboratory %RSD for all analytes from 16.8% (range 4.1-25.0) to 7.1% (range 4.1-11.0). Nuclear magnetic resonance analysis of the calibration material highlighted the need for standardization. The purities of isovaleryl-carnitine and glutaryl-carnitine were 85.13% and 69.94% respectively, below the manufacturer's stated values of ≥98%. For NBS programs provided by multiple laboratories using single analyte COVs, harmonization and standardization of results can be achieved by optimizing legacy FIA-MS/MS methods, adopting a common analytical protocol, and using standardized calibration material rather than internal calibration.

Sections du résumé

BACKGROUND
Newborn screening (NBS) laboratories in the United Kingdom adhere to common protocols based on single analyte cutoff values (COVs); therefore, interlaboratory harmonization is of paramount importance. Interlaboratory variation for screening analytes in UK NBS laboratories ranges from 17% to 59%. While using common stable isotope internal standards has been shown to significantly reduce interlaboratory variation, instrument set-up, sample extraction, and calibration approach are also key factors.
METHODS
Dried blood spot (DBS) extraction processes, instrument set-up, mobile-phase composition, sample introduction technique, and calibration approach of flow injection analysis-tandem mass spectrometry (FIA-MS/MS) methods were optimized. Inter- and intralaboratory variation of methionine, leucine, phenylalanine, tyrosine, isovaleryl-carnitine, glutaryl-carnitine, octanoyl-carnitine, and decanoyl-carnitine were determined pre- and postoptimization, using 3 different calibration approaches.
RESULTS
Optimal recovery of analytes from DBS was achieved with a 35-min extraction time and 80% methanol (150 μL). Optimized methodology decreased the mean intralaboratory percentage relative SD (%RSD) for the 8 analytes from 20.7% (range 4.1-46.0) to 5.4% (range 3.0-8.5). The alternative calibration approach reduced the mean interlaboratory %RSD for all analytes from 16.8% (range 4.1-25.0) to 7.1% (range 4.1-11.0). Nuclear magnetic resonance analysis of the calibration material highlighted the need for standardization. The purities of isovaleryl-carnitine and glutaryl-carnitine were 85.13% and 69.94% respectively, below the manufacturer's stated values of ≥98%.
CONCLUSIONS
For NBS programs provided by multiple laboratories using single analyte COVs, harmonization and standardization of results can be achieved by optimizing legacy FIA-MS/MS methods, adopting a common analytical protocol, and using standardized calibration material rather than internal calibration.

Identifiants

pubmed: 35699503
pii: 6608182
doi: 10.1093/clinchem/hvac070
doi:

Substances chimiques

Carnitine S7UI8SM58A

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1075-1083

Informations de copyright

© American Association for Clinical Chemistry 2022.

Auteurs

Rachel S Carling (RS)

Biochemical Sciences, Viapath, Guys & St Thomas' NHSFT, London, UK.
GKT School Medical Education, Kings College London, London, UK.

Emily Whyte (E)

National Measurement Laboratory, LGC, Teddington, UK.

Catharine John (C)

Biochemical Sciences, Viapath, Guys & St Thomas' NHSFT, London, UK.

Rachelle Garstone (R)

Chemical Pathology, Epsom & St Helier, London, UK.

Philippa Goddard (P)

Newborn Screening & Biochemical Genetics, Birmingham Children's Hospital, Birmingham, UK.

Toby Greenfield (T)

Newborn Screening, Blood Sciences, Queen Alexandra Hospital, Portsmouth, UK.

Sarah L Hogg (SL)

Biochemical Genetics, Cambridge University Hospitals-, Cambridge, UK.

Clare Le Masurier (C)

Newborn Screening & Biochemical Genetics, Southmead Hospital, North Bristol NHS Trust, Bristol, UK.

Simon Cowen (S)

National Measurement Laboratory, LGC, Teddington, UK.

Stuart J Moat (SJ)

Department of Medical Biochemistry, Immunology & Toxicology, University Hospital Wales, Cardiff, UK.
School of Medicine, Cardiff University, University Hospital Wales, Cardiff, UK.

Christopher Hopley (C)

National Measurement Laboratory, LGC, Teddington, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH